News
GlobalData on MSN19h
Lunit partners with Microsoft to develop AI cancer diagnostic toolsLunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice.
GlobalData on MSN19h
Vertex reports long-term results for Casgevy in sickle cell and thalassaemiaAcross 100 patients in three Phase III studies, Vertex's Casgevy showed lasting benefits for more than five years.
Pharmaceutical Technology on MSN21h
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancerThe approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback